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REVIEWS
Academic Detailing as a Possible Source of Drug 
Information in the Context of Nepal: A short review 
SAVAL KHANAL*, SUBISH PALAIAN**, P. RAVI SHANKAR***, PRANAYA 
MISHRA**, MOHAMED IZHAM MOHAMED IBRAHIM****
ABSTRACT
The source of unbiased drug information is an integral part of evidence based 
practice. The status of evidence based practice in Nepal is very poor. One of 
the major factors associated with it, is the limited availability of new literature, 
and poor documentation and dissemination of the little available information. 
Academic detailing is an educational outreach program in which a trained 
health professional visits clinicians in their offices to provide evidence based 
information. So, there is a huge scope for academic detailing as a means to 
disseminate the available information in the context of Nepal. Research done 
worldwide has already shown improvement in the clinicians’ knowledge, their 
attitude and practice, improvement in their prescribing patterns and an 
increase in their adherence to clinical guidelines, following academic detailing. 
In Nepal, there are many topics which can be selected for academic detailing. 
Topics covering the information regarding newer drugs, diarrhoea treatment 
guidelines, the rational use of antimicrobials, the rationality of fixed dose 
combinations, nonsteroidal antinflammatory drugs (NSAIDs) and specialized 
devices for the administration of drugs, will be more relevant. Lack of local 
health statistics, lack of awareness about evidence based practice, challenges 
from pharmaceutical representatives and a lack of financing capability may be 
the major limitations for academic detailing in Nepal.
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Introduction
Availability of a wide range of treatment 
options for the same condition may cause 
difficulty in clinical decision making. In 
such circumstances, sometimes clinicians 
may select the treatment option based on 
their opinion and experience without 
adequate information about the advantages 
and disadvantages of different options.  
However, the modern world cannot rely on 
the treatment based on the clinicians’ 
individual opinions and experience alone; 
instead, there is demand for scientific 
evidence and this has given rise to the 
concept of evidence based practice. 
Evidence based practice means the practice 
of using the most current research 
information to guide clinical decisions, 
while also fully taking into consideration the 
patient’s values and circumstances [1].
Evidence based practice promotes the 
rational use of medicines. One of the major 
problems associated with practicing rational 
use of medicines is the lack of reliable and 
unbiased scientific information available for 
patient care in the context of Nepal [2]. 
Sources of reliable and unbiased drug 
information thus, become an important 
element of evidence based practice. In 
circumstances where clinicians do not have 
reliable and unbiased sources of drug 
information, academic detailing may play a 
vital role to update clinicians with evidence 
based information. 
Academic detailing is an educational 
outreach program in which a trained health 
professional visits clinicians in their offices 
to provide evidence based information [3]. It 
is like a pharmaceutical representative 
visiting a physician, except that the 
information provided is evidence-based. 
Usually, it is given on a one-to-one basis; 
however, in some cases, it can be given to a 
small group of clinicians [4]. It is also 
known as an educational outreach or an 
outreach visit.
Nepal is a developing country with 
inadequately developed drug information 
services. In this article, the authors provide 
an overview of academic detailing as a 
source of drug information and its scope in 
Nepal. The authors have also tried to discuss 
here, possible strategies to run an academic 
detailing program in Nepal, and its 
limitations.
Status of drug Information in Nepal
Historically, in the year 1995, the National 
Drug Policy of Nepal for the first time, 
emphasized the dissemination of accurate 
and unbiased drug information within the 
country. To fulfill this objective, the Drug 
Information Network of Nepal (DINoN) was 
established on November 23, 1996. The 
mission of DINoN was to develop and 
disseminate drug information among the 
members. At present, there are nine 
members of DINoN. Though more than one 
and a half decade has been already been 
spent, there has been no increase in the 
number of members of DINoN [5].
The activity of a drug information center in 
one of the teaching hospitals in Nepal is 
commendable. It has gone just beyond 
providing drug information. It provides drug 
information services to clinicians and other 
healthcare professionals, provides
medication counseling to patients and their 
parties, runs a pharmacovigilance center, 
running continuing education programs and 
promoting the rational use of medicines 
inside the hospital [6]. Similarly, an article 
from Nepal has suggested that one of the 
teaching hospitals in Nepal is running DIC 
as a pilot project [7].
Though the scenario of drug information 
services is improving, it is doing so in a very 
slow manner. Within the last five years, 
there has not been an appreciable increase in 
the number of drug information centers 
associated with DINoN. Limited availability 
of new literature and poor documentation 
and dissemination of the little available 
information, are the main limitations for 
drug information services in Nepal [8].
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Justification for academic 
detailing
The advantages of the academic detailing 
and the associated advantages are discussed 
below under different subheadings.
1. Academic detailing improves the 
knowledge, attitude and practice of 
healthcare professionals
The thorough discussion of a topic during 
academic detailing can improve the 
knowledge, attitude and practice of the 
healthcare professionals on that topic.  
Studies conducted in Kenya and Indonesia 
had found a significant improvement in the 
knowledge and performance of pharmacists 
with respect to the treatment of diarrhoea [9].
Similarly, other studies from Australia have 
suggested that academic detailing may have 
an impact on the physicians’ knowledge and 
self-perceived understanding of evidence 
based medicine [10].
2. Academic detailing improves the 
prescribing pattern of clinicians
Certain studies done worldwide, have 
demonstrated improvement in the 
prescribing pattern of clinicians following 
academic detailing. Meperidine, an opioid
analgesic, is not recommended as the first 
line drug for pain management because of 
safety and efficacy concerns. In a hospital in 
the United States, it was found that there 
was an increased use of Meperidine. 
However, academic detailing reduced the 
use of Meperidine in the hospital [11]. A 
study conducted in Sweden has concluded 
that there was a marked improvement in the 
prescription pattern of antipsychotics and 
benzodiazepines after academic detailing 
[12]. Another study from Spain has 
demonstrated the positive impact of 
academic detailing on the prescribing 
pattern of Nonsteroidal Anti-inflammatory 
Drugs (NSAIDs) [13]. All the studies 
suggest that academic detailing can improve 
the prescribing pattern of clinicians.
3. Academic detailing increases adherence 
to the clinical guidelines
Translating guidelines into practice has been 
the main problem in health sciences. 
Academic detailing can be used as one of 
the interventional programs to increase the 
clinicians’ adherence to the guidelines [14]. 
Academic detailing has been successful in 
increasing the clinicians’ adherence to the 
guidelines. A study conducted in Australia 
states that the clinician’s adherence to the 
antibiotic guidelines was increased after 
academic detailing. They found that 
academic detailing remarkably decreased the 
number of antibiotic prescriptions and the 
total treatment costs [15]. Similarly, in 
another study conducted in a hospital in the 
United States, academic detailing was useful 
in implementing new guidelines for treating 
hypertension [16]. Therefore, academic 
detailing can be used as an informational or 
educational intervention to facilitate the 
implementation of clinical guidelines.
4 The perception of clinicians about 
academic detailing
Evidence based educational outreach visits 
are incrementally more effective than 
conventional educational sessions [14]. The 
clinicians’ perception about academic 
detailing can be vital to bring behavioural 
changes in them. Some of the studies carried 
out on the perception of the clinicians 
towards academic detailing suggest that the 
clinicians appreciated academic detailing as 
a good means to update their knowledge. In 
a research conducted in Belgium, physicians 
rated academic detailing visits highly and 
approximately 90% of those who used 
academic detailing wished to use it again 
[17]. Similarly, clinicians valued academic 
detailing as an important source to get 
evidence based information and a study 
from Canada reported that despite being a 
source of valuable information, it is time-
consuming [18].  
5. The sustainability of academic detailing
To start a program is somehow easier than to 
sustain it. One article has reported that after 
a 10 year practice, academic detailing has 
become a sustainable source of drug 
information in Sweden.  It has been 
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transformed from project to practice [19]. 
However, another article from Canada 
suggested that one academic detailing center 
was closed and some are in the way of
closure because expected outcomes were not 
comparable to the investment in those 
academic detailing centers [20], suggesting 
that lack of economic strength can be one of 
the major limitations for academic detailing 
centers. 
Need of academic detailing in 
Nepal
Academic detailing is known to improve the 
understanding of evidence based medicine 
[10].  There is very limited data on evidence 
based practice in Nepal. On observation, one 
can find that the practice of managing a 
particular condition in almost the same type 
of individuals greatly varies between
clinicians, suggesting that the status of 
evidence based practice is very poor in 
Nepal. An unbiased source of drug 
information is the heart of evidence based 
practice. But contrary to this, upon 
observation, one can hardly find good 
reference books and other unbiased sources 
of drug information for the clinicians and 
healthcare professionals in Nepal [21], [22]. 
In such a scenario, the information which 
the clinicians or other healthcare 
professionals had obtained from their 
academic studies becomes the means of drug 
information for them. On other hand, due to 
the emergence of many pharmaceutical 
companies, clinicians are at a high risk of 
receiving biased information from their 
pharmaceutical representatives in Nepal [23]. 
Therefore, in the case where there is a lack 
of unbiased sources of drug information, 
academic detailing can serve as a means of 
unbiased scientifically proven drug 
information. For such healthcare 
professionals, the academic detailing 
program becomes more suitable. By this 
way, the educational intervention in the 
form of academic detailing may promote the 
concept of evidence based practice in Nepal.
There are so many areas where academic 
detailing can contribute in Nepal. With the 
help of some health statistics, drug 
utilization studies and some 
pharmacoepidemiological studies, the 
authors try to postulate some of the 
important topics which can be focused 
during academic detailing. Those topics are 
mentioned in [Table/Fig 1].
How academic detailing can be 
conducted in Nepal?
Ros- Degnan et al has suggested four steps 
to the healthcare professional to carry out an 
educational intervention. These four steps 
are (1) Assess knowledge and actual 
treatment practices (2) Identify underlying 
motivations and constraints to changing 
practices (3) Design a persuasive 
educational intervention and (4) Carry out 
and evaluate the intervention [39]. The 
authors of this article have proposed a model 
method for conducting academic detailing in 
Nepal, based on the method of Ros-Degnan 
et al as discussed above. The proposed 
method is diagrammatically illustrated in 
[Table/Fig 2]. 
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Expected limitations in conducting 
academic detailing in Nepal
In a study conducted in the Netherlands, 
clinicians identified some barriers in the way 
of the participation in academic detailing. 
The barriers identified by them were –the 
information in academic detailing was not 
new and could be obtained in other ways, 
the information was politically coloured and 
was designed to cut expenses and the 
educational visits were time-consuming [40]. 
These types of limitations can also be 
expected in Nepal: however, the barrier of 
academic detailing to cut expenses may not 
be relevant to Nepal as there is no third 
party payment system in Nepal. In addition 
to the above limitations, some other 
expected limitations in Nepal are as follows:
1. Lack of local health statistics
This may cause a difficulty in selecting the 
medicines for which academic detailing 
should be prioritized. This may also cause 
problems in getting the information 
regarding the therapeutic efficacy and safety 
profile of the medicines in the local 
population.
2. Lack of awareness about evidence based
practice
Since clinicians in Nepal are less aware 
about evidence based practice and rely 
mostly on their personal judgment and 
experience for clinical decision-making, 
they may not take academic detailing to be 
an important means of drug information.
3. Challenge from pharmaceutical 
representatives
Since the aim of both pharmaceutical 
representatives and academic detailers are to 
bring changes in the prescribing pattern of 
clinicians, it may be difficult for academic 
detailers to compete with the financial 
strength of pharmaceutical companies.
4. Lack of financing capability
More resource persons need to be appointed 
and bulletins and information leaflets may 
be needed. In such cases, economic 
problems may limit academic detailing. 
Sometimes, clinicians may also demand 
some bursaries to spend time on academic 
detailing. Apart from this, travel and other 
allowances are also required for academic 
detailers. So, there will be a demand for a
budget to conduct academic detailing. 
Conclusion
Though the scenario of the drug information 
services in Nepal is changing, it is not 
progressing in an expected manner. The 
status of evidence based practice is poor in 
this country. In this article, we have 
discussed the scope of academic detailing as 
the source of drug information in the 
Nepalese perspective. Academic detailing 
has already been practiced in other countries 
and has been shown to have a positive 
impact on promoting evidence based 
practice. The authors of this article have 
proposed a model to conduct academic
detailing programs in Nepal. More research 
on the impact of academic detailing in the 
context of Nepal is required.
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